Staying on Target: Reducing CV Risk by Achieving LDL-C Targets With Statin and Nonstatin Therapies

Learn the latest evidence on the comprehensive management of dyslipidemia, including the importance of achieving LDL-C targets and addressing elevated Lp(a), to reduce ASCVD risk through expert-written ClinicalThought commentaries, downloadable slides, and an on-demand webcast.

Share

Program Content

Activities

Implementing LDL-C Lowering Therapy
Call to Action: The Importance of ASCVD Risk Assessment and Achieving Targets Through Personalized LDL-C–Lowering Treatment Plans
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: April 05, 2024

Expires: April 04, 2025

Q&A on Targeting LDL-C
Expert Answers to Frequently Asked and Compelling Questions on Meeting LDL-C Targets
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: May 10, 2024

Expires: May 09, 2025

Activities

Slides on Targeting LDL-C
Staying on Target: Reducing CV Risk by Achieving LDL-C Targets With Statin and Nonstatin Therapies
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: April 15, 2024

Expires: April 14, 2025

Activities

Targeting LDL Cholesterol
Staying on Target: Reducing CV Risk by Achieving LDL-C Targets With Statin and Nonstatin Therapies
Video
Congratulations: You achieved a completion on 04/09/2022

Released: April 23, 2024

Expires: April 22, 2025

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by an educational grant from Novartis Pharmaceuticals Corporation.

Novartis Pharmaceuticals Corporation